| COPD |
|
Pulmonary disease, chronic obstructive, severe early-onset
|
|
|
0.456 |
0.885 |
| LINC01672 |
|
long intergenic non-protein coding RNA 1672
|
|
|
0.462 |
0.846 |
| MS |
|
multiple sclerosis
|
|
|
0.599 |
0.692 |
| PSS |
|
Potocki-Shaffer syndrome
|
|
|
0.608 |
0.654 |
| HCA1 |
|
Hypercalciuria, absorptive, 1
|
|
|
0.633 |
0.654 |
| TEC |
|
transient erythroblastopenia of childhood
|
|
|
0.659 |
0.577 |
| BAS |
|
Beta-adrenergic stimulation, response to
|
|
|
0.711 |
0.346 |
| GULOP |
|
gulonolactone (L-) oxidase, pseudogene
|
|
|
0.805 |
0.308 |
| AGRP |
O00253
|
agouti related neuropeptide
|
Signaling
|
7.0E-04 |
0.488 |
0.769 |
| FAAH |
O00519
|
fatty acid amide hydrolase
|
|
4.4E-11 |
0.545 |
0.692 |
| KRIT1 |
O00522
|
KRIT1 ankyrin repeat containing
|
|
6.9E-04 |
0.500 |
0.808 |
| CXCR6 |
O00574
|
C-X-C motif chemokine receptor 6
|
G-protein coupled receptor
|
5.7E-05 |
0.448 |
0.885 |
| SYNM |
O15061
|
synemin
|
|
3.0E-24 |
0.575 |
0.731 |
| GPR42 |
O15529
|
G protein-coupled receptor 42 (gene/pseudogene)
|
G-protein coupled receptor
|
5.1E-02 |
0.475 |
0.846 |
| PER1 |
O15534
|
period circadian regulator 1
|
Transcription factor
|
2.9E-04 |
0.556 |
0.731 |
| DCX |
O43602
|
doublecortin
|
|
0.30 |
0.511 |
0.769 |
| HCRT |
O43612
|
hypocretin neuropeptide precursor
|
|
2.9E-02 |
0.500 |
0.808 |
| FCGR3B |
O75015
|
Fc fragment of IgG receptor IIIb
|
Cell adhesion
|
3.0E-07 |
0.452 |
0.962 |
| PPFIA2 |
O75334
|
PTPRF interacting protein alpha 2
|
|
1.00 |
0.861 |
0.154 |
| NR1I2 |
O75469
|
nuclear receptor subfamily 1 group I member 2
|
Nuclear receptor
|
7.3E-09 |
0.418 |
0.846 |
| RGS20 |
O76081
|
regulator of G protein signaling 20
|
Enzyme modulator
|
6.4E-05 |
0.760 |
0.269 |
| BEST1 |
O76090
|
bestrophin 1
|
Ion channel
|
1.8E-12 |
0.465 |
0.885 |
| JTB |
O76095
|
jumping translocation breakpoint
|
|
0.42 |
0.615 |
0.769 |
| ABCA1 |
O95477
|
ATP binding cassette subfamily A member 1
|
Transporter
|
1.5E-13 |
0.467 |
0.846 |
| BAG3 |
O95817
|
BAG cochaperone 3
|
|
0.62 |
0.498 |
0.846 |